← Open Payments lookup

MARK CHANDLER: Open Payments

NPI 1265452270 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,651 in 158 payments from 16 companies in 2025. Trend: 2023 $2,421 · 2024 $2,771 · 2025 $2,651

Food & beverage: $2,651
CompanyPaymentsAmount
Alkermes, Inc.36$511
Vanda Pharmaceuticals Inc.24$419
Otsuka America Pharmaceutical, Inc.17$384
ABBVIE INC.21$329
Teva Pharmaceuticals USA, Inc.10$176
Janssen Pharmaceuticals, Inc10$166
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$154
E.R. Squibb & Sons, L.L.C.8$135
Lundbeck LLC5$118
Neurocrine BioSciences, Inc.5$87

Products named: ARISTADA, HETLIOZ, REXULTI, VRAYLAR, CAPLYTA, AUSTEDO XR, COBENFY, ABILIFY ASIMTUFII.

Industry payments across NC — which companies pay providers there.